Event Brief
Personalized melanoma mRNA vaccine shows promise
By The BriefBrief · Sources (1)
Filed: Aug 26, 2026 at 6:00 PM ET
Summary: Moffitt Cancer Center in Tampa is participating in a Phase 3 clinical trial of a personalized mRNA vaccine for melanoma. Doctors create the treatment from mutations found in a patient’s tumor after surgery, aiming to help prevent the cancer from returning.
WHO: Moffitt Cancer Center doctors and patients enrolled in the Phase 3 trial
WHAT: A personalized mRNA vaccine immunotherapy for melanoma, built from each patient’s tumor mutations after surgery
WHEN: Aug 26, 2026 at 5:19 PM ET
WHERE: Tampa, Florida
WHY: The trial is based on using mutations unique to a patient’s tumor to create an individualized immunotherapy designed to help prevent melanoma from returning.
ℹ️ This event is analyzed using pattern arcs, velocity indicators, and source analysis in our MI Console.
Study links fossil pollution to California water woes
California
Aug 26, 2026 at 6:00 PM ET
🔒
Pride & Passion marks 20 years at Tampa Museum
Pride & Passion
Aug 26, 2026 at 6:00 PM ET
🔒
Manatee County blocks Flock cameras at parks
Manatee County
Aug 26, 2026 at 6:00 PM ET
🔒
Pinellas deputy surprised with KidsFirst award
Pinellas County
Aug 26, 2026 at 6:00 PM ET
🔒
